Do You Take Two Insulins to Treat Your Type 2 Diabetes?

Updated on 22 October 2021
hemoglobin a1c
continuous glucose monitoring


We are currently seeking volunteers who are diagnosed with Type 2 Diabetes and who are treating with a Basal/Bolus insulin regimen.
(Participants can also be treating with up to 3 other oral diabetes medications. They can also be taking injectable GLP-1 medications and qualify. Medications need to be stable for 90 days.)

Qualifying Insulins:
  • Basal insulin: Lantus or Basaglar (Glargine)
  • Bolus insulin: Humalog (Lispro), Novolog (Aspart), or Apidra (Glulisine).
  • With or without up to 3 of the following:
    • Metformin
    • Januvia, Onglyza, Tradjenta, or Nesina. (DPP-4’s)
    • Farxiga, Invokana, or Jardiance. (SGLT2’s)
    • Rybelsus (Oral GLP-1)
  • Participants may also be currently taking injectable GLP-1s: Byetta, Bydureon, Victoza, Tanzeum, Trulicity, or Ozempic.
This is a study of an investigational injectable meal-time insulin that may help to better regulate blood sugar levels through the use of a Continuous Glucose Monitoring (CGM) System. All participants will continue or start taking Basaglar insulin (glargine-U100). All participants will also start taking the investigational meal-time insulin 3 times a day (before breakfast, lunch, and dinner). Participants may continue the use of their current stable OAMs or injectable GLP-1s throughout the study.


Study Length: 19 weeks, with 6 clinic visits and 7 telephone appointments.

Target Age: 18+ years old.

Benefits: Participants will receive the following at no cost: All of their insulin (Basaglar and study medication [bolus insulin]), study related physical exams, EKGs, lab work, use of the Freestyle Libre CGM, a glucose meter, test strips and other supplies.

Stipend: $625 for study completion ($75 per clinic visit and $25 per telephone visit.)

Condition insulin, Diabetes Mellitus Type 2, Diabetes (Pediatric), Diabetes, Diabetes Mellitus Types I and II, Diabetes Prevention, Diabetes Mellitus, Type 2
Clinical Study IdentifierTX267207
Last Modified on22 October 2021


Yes No Not Sure

Inclusion Criteria

Must have a Type 2 Diabetes diagnosis for at least 1 year
Must be treating with basal (long acting) and bolus (short acting) insulin
Must have an HbA1c between 7.5-10.0% at screening
Must have a BMI ≤ 40
Must meet other eligibility criteria. Please contact us for further details
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact


Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note